Objective. Incidence of OA rises steeply in women of age >50 years; the climacteric period for women. The simultaneous occurrence of these events suggests an association between OA and changes in female hormonal aspects. This systematic review studies the assumed association between OA and aspects concerning the fertile period (duration, endogenous hormones, age at menarche/menopause) and the menopause [menopausal status, years since menopause (YSM) and surgical menopause]. Methods. Medline and EMBASE were searched for articles assessing associations between hand/hip/knee OA and female hormonal aspects. Methodological quality was assessed systematically, and results were summarized in a best-evidence synthesis.
Introduction
Prevalence of OA is higher in women than in men, and incidence rises with ageing. Incidence of this common progressive joint disease rises faster in women than in men after the age of 50 years [1] ; around the same age of the climacteric transition in women. In studying the association between exogenous hormone use and OA in a previous systematic review [2] , we found no convincing evidence of an association. We did, however, find a limited protective trend for incidence of total hip replacement for hysterectomized women using unopposed oestrogen, but, given the prevalence of this determinant, this does not explain the rise in incidence.
Menopausal women have lower oestrogen levels than normal menstruating women [3] . Considering this, and the sex-specific incidence and prevalence difference, oestrogen may play a role in OA regulation. Determinants influencing endogenous, longterm serum oestrogen levels, defined by the fertile period or menopause, may be associated with OA development. The aim of this systematic review is to gain insight in the current stage of knowledge on the association between OA and female hormonal aspects.
Methods
The methods used in this systematic review are similar to those previously described in our review on OA and HRT use [2] . Here the methods are repeated shortly.
Study identification
The articles were identified by systematically searching the databases of Medline and EMBASE up to October 2008. Inclusion criteria and keywords (osteoarthritis, oestrogen, menopause, ovariectomy and equivalents of these words) are shown in Appendix I available as supplementary data at Rheumatology Online. The search was extended by screening the reference lists of all included studies and relevant reviews.
Methodological quality
The methodological quality of the included studies was based on previously used lists [4, 5] [Appendix IIa, with specifications in Appendix IIb (available as supplementary data at Rheumatology Online)], but it is modified to cover our topic and concerns both the internal validity and informativeness of the article.
All articles were scored independently by two reviewers and consensus was aimed for in case of disagreement.
Evidence synthesis
Evidence from homogeneous studies was pooled. In case of heterogeneity, we refrained from statistical pooling and performed a 'best-evidence synthesis' [5, 6] .
A study was considered to be of high quality if the methodological score was 560%. The best evidence synthesis was performed using the following levels of evidence [5, 7] : (i) strong evidence: consistent findings (>75%) in multiple high-quality studies; (ii) moderate evidence: consistent findings (>75%) in one high-quality study and some other low-quality studies or multiple low-quality studies; (iii) limited evidence: only one high-quality study; (iv) conflicting evidence: inconsistent findings in several studies of equal quality;
(v) insufficient evidence: less than two low-quality studies available; and (vi) no evidence: provided when no studies could be found.
In the evidence synthesis, a subdivision is used for the type of OA: (i) radiological OA (ROA), indicating radiological changes only, and (ii) clinical OA (COA), indicating complaints of pain and stiffness in the described joint or presence of palpable Herberden's nodes (HN), with or without radiological changes present in the same joint. COA includes total hip (THR), knee (TKR) or joint replacements (TJR, hip or knee).
Data extraction
Two researchers independently collected characteristics of the included studies. Extracted outcomes are relative risks or odds ratios (ORs), and were dichotomized into significant outcomes (association present) and non-significant outcomes (no association present) [6] .
Results

Study identification and methodological quality
The systematic search resulted in the identification of 464 references that were screened on title and abstract, leading to the inclusion of 17 studies. Figure 1 shows the flow chart of the selection process. The two reviewers each scored 266 items from 16 studies, and initially agreed on the quality score of 194 items (73%, ¼ 0.54). Table 1 gives a description of the characteristics of the included studies. The quality scores of the included studies are presented in Appendix III available as supplementary data at Rheumatology Online.
Heterogeneity
All included studies were heterogeneous with regard to the determinants, outcome measures and study population, causing clinical heterogeneity and making statistical pooling illogical. Even within the studied determinants, heterogeneity on these points was too large to justify pooling. Therefore we performed a best evidence synthesis for all studied determinants.
Hormonal aspects
The hormonal aspects reviewed are related to the fertile period and menopause, and $50% of the studies report on multiple aspects ( Table 2 ). The hormonal aspects included are: endogenous hormones [8, 9] , age at menarche and/or menopause [10] [11] [12] [13] [14] , duration of fertile period [11, 12] , menopausal status [8, 12, 14, 18, [21] [22] [23] , years since menopause (YSM) [12, 22, 16] and surgical menopause [12, [17] [18] [19] [20] .
Endogenous hormones
Sowers et al. studied oestradiol serum levels in OA and reported in their studies in 1996 [8] and 2006 [9] . In 2006, they used a combination of two separate cohorts (SWAN and MBHS) collectively known as the Southeast Michigan Arthritis Cohort study, and found that women who had baseline endogenous early-follicular phase oestradiol concentrations in the lowest tertile had greater odds of developing knee ROA.
The study population of Sowers et al. in 1996 was also included in the 2006 study; therefore, only the 2006 study is considered for evidence synthesis. Considering this, limited evidence is seen for significant increased risk between lower blood oestradiol levels and incident knee ROA. No relation was seen for this with prevalence of knee ROA.
Age at menarche and/or menopause
Four studies report on the relation between OA and the age at menarche [10, 11, 13, 14] and four on age at menopause [10] [11] [12] 14] . Two studies found a negative association: Kalichman and Kobyliansky [13] found an association with hand ROA and Liu et al. [14] with THR. Both found that the younger age at menarche increases the risk of OA. The other studies did not find such associations [10] [11] [12] .
The Zoetermeer study [12] reported a higher menopausal age (551 years) to increase the risk of having HN, whereas for TKR, due to OA, The Million Women Study [14] found age at menopause 552 years old to be protective. For age at menarche with hand ROA, the evidence is conflicting. For THR, limited evidence was seen for a significantly increased risk of age at menarche being 411 years. For cut-off points with older ages, the evidence was limited for no relation with the same trend for hip ROA. For TKR and age at menarche evidence of no relation was seen.
Conflicting evidence was seen for age at menopause being 551 years with hand COA (HN); for other ages and for age at menopause with CMC and DIP ROA, the evidence was strong in the direction of no relation. Limited evidence was found for no relation for THR with age at menopause and the same trend with hip ROA. For TKR, limited evidence was seen for a borderline
Studies identified in databases and screened by two reviewers (n =464)
Excluded studies (n=415) based on title and/or abstract because: -the article did not describe data of own original human population, -disease of interest was not OA of the hand, hip or knee and studied in both people with and without OA, -no female hormone changing event was studied, -the study aim was genetics and -the article was not written in Dutch, English, Danish, Norwegian, German, Swedish or African.
Studies retrieved for full text examination by two reviewers (n=49)
Excluded studies (n = 23) because no relevant outcome on an association of a female-hormonal aspect with OA was described.
Studies initially included (n=26)
Excluded studies (n = 11); four studies did not specify which joint was affected, in six studies no relevant outcomes were given, nor was it possible to calculate them from the available data and one study did not give a cut-off point for OA. Screening the reference lists of the remaining studies resulted in the inclusion of one additional study.
Studies included in the total systematic review (n =16). All cases had been referred with symptomatic lower limb radiological OA. Controls recruited from same general practice as cases attended.
MP status
Studies are ranked in descending order of quality.
a Assessment manner for OA either radiographic (X-ray) or symptomatic (symptoms).
The study population used by Oliveria et al. [18] was obtained from their previous study on oestrogen replacement therapy [21] . In this review, the populations are considered different due to differences in mean BMI and mean age of the described study populations. THR: total hip replacement; TKR: total knee replacement; N-CS: (nested) cross-sectional study; CC: case-control study; Dur. fertile: duration of fertile period in a woman's life (age menopause/age menarche); MP: menopause; YSM: years since menopause; Age men: Age menarche. significant protective effect of age at menopause being 552 years, but not with younger ages; there the evidence was in the direction of no relation.
Duration of fertile period
The duration of the fertile period with hand OA was studied by two groups [11, 12] , one of which found a non-significant increased risk for a duration of 536 years [12] . Further, no associations were found for this determinant.
Only the evidence for an association with hand ROA and presence of HN was found, this was strong in the direction of no relation.
Menopausal status
Seven studies reported on the association of menopausal status of women with OA [8, 12, 18, [21] [22] [23] . For one study [21] , the association between COA and the menopausal status was calculated by us. In the Zoetermeer study [12] , an increased risk was found between natural menopause and hand COA (HN), but not with hand ROA.
In prevalence studies, strong evidence was found for no relation between menopausal status and hand ROA. Limited evidence was seen for a borderline significant increased risk with hand COA. In incidence studies, the same trend of no relation with hand COA was seen.
For knee OA, limited evidence was seen for a significantly protective effect of being post-menopausal for the highest knee score, but this effect disappeared in a multivariate model, leaving evidence of no relation. Moderate evidence was seen for no relation between knee ROA score 52 and menopausal status, and limited evidence for no relation with THR and TKR.
YSM
In studying the YSM, no relationship with hand ROA or hip ROA [12, 15] was found. But, one study found YSM to be (weakly) correlated with the Kellgren and Lawerence grade (K&L scale) of the knee [16] .
YSM was studied only in prevalence studies and even then the evidence for an association with hip, knee or 'any joint' ROA was insufficient. There was moderate evidence for no association between YSM and hand ROA (independent of number of YSM), whereas the evidence with knee ROA was conflicting. Limited evidence was found for a non-significant increased risk of YSM of 1-4 years with hand COA.
Surgical menopause: ovariectomy
Four studies describe the relation between the surgical menopause (ovariectomy) and OA [12, 17, 19, 20] . One study [20] reports an increased prevalence of hip COA, whereas another reports a bilateral ovariectomy to be protective for hip ROA [19] . Spector et al. [17] reports that the rate of OA for most joint groups was lower in those women who had both their ovaries removed compared with women who maintained at least one (data not shown).
Ovariectomy was studied only in prevalence studies. For hand OA, strong evidence was found for no relation, the same relation was seen for knee ROA but with limited evidence. For hip OA, the trend of evidence was conflicting with two low-quality studies, one is ovariectomy to be protective for ROA and the other increasing risk for COA.
No clear differences in outcomes were found when dividing the studies on the basis of (i) optimal adjustment for confounders (age, BMI, BMD and HRT use), (ii) ROA or COA, (iii) menopausal status of the population or (iv) study size. The 95% CI combined with given OR seems incorrect, but given by authors. HQ: high-quality study (if not mentioned: low-quality study); CC: case-control study; duration fertile: as the number of years between age at menopause and age at menarche; THR: total hip replacement; nodes (HN/B): Herberdens' nodes or Bouchards; N-CS: (nested) cross-sectional study; COA: clinical OA; surgical MP: bilateral ovariectomy at the age at which menstruation stopped; NC: not calculated; ROA: radiological OA.
Discussion
The assumed relationship between the studied female hormonal aspects and OA of the hand, hip or knee was not clearly observed in this systematic review. Most evidence points in the direction of no relation between OA of hand, hip and knee and the studied determinants remain conflicting.
To our knowledge, we are the first to systematically review the literature on these associations, providing a comprehensive overview on the subject.
From animal studies it is shown that removing the ovaries is not equal, concerning hormonal influence, to a natural menopause [24, 25] . Considering this, it may not be completely fair to compare women with ovariectomy and those with natural menopause. The studied determinants are all intertwined, making it difficult to study them individually and leading to possible confounding of determinants mutually. Data collection in the individual studies was sometimes questionable due to limited information presentation on the determinants, possibly contributing to the fact as to why no hard evidence was found.
The association between OA and female hormonal aspects has been studied from different angles. Sniekers et al. [26] systematically reviewed the association between OA and ovariectomy in animal studies and found inconclusive evidence. We reviewed the association between OA and HRT [2] , and also found the association to be unclear, and now again, we found the same evidence in epidemiological studies for female hormonal aspects. One would expect that if an association is present, this would also be found in a large enough epidemiological study.
In the evidence synthesis used in this review, all non-significant outcomes were interpreted as evidence of no relationship between the studied determinant and OA. Still, it is possible that a relationship is present, but it could not be found using the applied study designs and the corresponding sample sizes. When pooling is not possible, the risk exists that small studies showing effect, but not significantly, are defined as negative studies. However, of all our relative small studies (n < 500) three studies were classified as low quality and the other two showed OR of %1. The next smallest studies (n ¼ 573, n ¼ 645, respectively) [8, 12] both showed significant results. We therefore think that our results are not biased by small studies.
For future research on OA and female hormonal aspects, we suggest to use a large number of subjects (at least 500), at least adjust for age and BMI, and if possible, collect data on suspected effect modifiers (e.g. oestrogen-related genes). In studying ovariectomy and OA, we recommend to specify number of ovaries removed and possible usage of HRT. We hoped that gaining insight in the association between OA and female hormonal aspects would contribute to the formulation of a high-risk profile for OA development and a better understanding of OA aetiology. Unfortunately much remains unclear. The fact remains that incidence and prevalence rise quickly in women after the age of 50 years. Possibly the relationship between female hormonal aspects and OA of hand, hip and knee is too complex to appear in epidemiological research as such, or other aspects, yet to be determined, play a role in the increased incidence in women after the age of 50 years.
Rheumatology key message
Most evidence points towards no relation between OA and female hormonal aspects, or remains conflicting.
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